Methionine intolerance: a possible risk factor for coronary artery disease
DR Murphy-Chutorian,
MP Wexman,
AJ Grieco,
JA Heininger,
E Glassman,
GE Gaull,
SK Ng,
F Feit,
K Wexman,
and
AC Fox
Homocystinuria, an inherited disorder associated with premature atherosclerosis, represents a severe form of methionine intolerance. To analyze the importance of milder forms of methionine intolerance in the genesis of vascular disease, the relation between provokable methionine intolerance and coronary artery disease was investigated. In a group of 138 men, aged 31 to 65 years (mean 53), referred for cardiac catheterization, plasma homocystine was measured before and 6 hours after an oral l-methionine load (0.1 g/kg). Thirty-nine subjects found to have normal coronary arteries had a mean post-load plasma homocystine level of 0.59 +/- 0.37 mumol/liter. A criterion at the 95th percentile (1.64 SD above the mean) was selected and applied to the remaining 99 subjects with coronary artery disease (0.70 +/- 0.68 mumol/liter). Sixteen (16%) of 99 subjects with coronary artery disease exceeded this level as compared with 1 (2%) of 39 subjects without coronary artery disease (p less than 0.04). The risk of coronary artery disease in men with provokable methionine intolerance was increased sevenfold as estimated by the odds ratio. By correlation matrix and multivariate regression analyses, provokable homocystinemia was predictive of coronary artery disease and was independent of tobacco smoking, hypertension, diabetes mellitus, serum cholesterol and age. It is proposed that men with mild methionine intolerance exposed to the high methionine content of the Western diet may develop intermittent homocystinemia and thus may be at greater risk for the development of coronary artery disease.
This article has been cited by other articles:
|
|
|
|
 
S. Sen, S. M. Oppenheimer, J. Lima, and B. Cohen
Risk Factors for Progression of Aortic Atheroma in Stroke and Transient Ischemic Attack Patients
Stroke,
April 1, 2002;
33(4):
930 - 935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
Int. J. Epidemiol.,
February 1, 2002;
31(1):
59 - 70.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health
Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events
Can. Med. Assoc. J.,
July 1, 2000;
163(1):
21 - 29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Arch Intern Med,
February 28, 2000;
160(4):
422 - 434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D'Angelo and J. Selhub
Homocysteine and Thrombotic Disease
Blood,
July 1, 1997;
90(1):
1 - 11.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Boushey, S. A. A. Beresford, G. S. Omenn, and A. G. Motulsky
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease: Probable Benefits of Increasing Folic Acid Intakes
JAMA,
October 4, 1995;
274(13):
1049 - 1057.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. A. Mansoor, C. Bergmark, A. M. Svardal, P. E. Lonning, and P. M. Ueland
Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease : Homocysteine and Peripheral Vascular Disease
Arterioscler Thromb Vasc Biol,
February 1, 1995;
15(2):
232 - 240.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. J. Stampfer, M. R. Malinow, W. C. Willett, L. M. Newcomer, B. Upson, D. Ullmann, P. V. Tishler, and C. H. Hennekens
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
JAMA,
August 19, 1992;
268(7):
877 - 881.
[Abstract]
[PDF]
|
|
|
|
